PLAYSTUDIOS INC (MYPS) Fundamental Analysis & Valuation

NASDAQ:MYPS • US72815G1085

Current stock price

0.417 USD
+0 (+0.46%)
At close:
0.4115 USD
-0.01 (-1.32%)
After Hours:

This MYPS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MYPS Profitability Analysis

1.1 Basic Checks

  • In the past year MYPS has reported negative net income.
  • MYPS had a positive operating cash flow in the past year.
  • In the past 5 years MYPS reported 4 times negative net income.
  • Each year in the past 5 years MYPS had a positive operating cash flow.
MYPS Yearly Net Income VS EBIT VS OCF VS FCFMYPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -9.85%, MYPS is doing worse than 62.03% of the companies in the same industry.
  • MYPS has a Return On Equity (-12.57%) which is in line with its industry peers.
Industry RankSector Rank
ROA -9.85%
ROE -12.57%
ROIC N/A
ROA(3y)-8.01%
ROA(5y)-5.18%
ROE(3y)-10.34%
ROE(5y)-6.68%
ROIC(3y)N/A
ROIC(5y)N/A
MYPS Yearly ROA, ROE, ROICMYPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • MYPS has a Gross Margin of 75.56%. This is amongst the best in the industry. MYPS outperforms 83.54% of its industry peers.
  • In the last couple of years the Gross Margin of MYPS has grown nicely.
  • The Profit Margin and Operating Margin are not available for MYPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.3%
GM growth 5Y2.71%
MYPS Yearly Profit, Operating, Gross MarginsMYPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. MYPS Health Analysis

2.1 Basic Checks

  • MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MYPS has been increased compared to 1 year ago.
  • Compared to 5 years ago, MYPS has less shares outstanding
  • MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYPS Yearly Shares OutstandingMYPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MYPS Yearly Total Debt VS Total AssetsMYPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.18, we must say that MYPS is in the distress zone and has some risk of bankruptcy.
  • MYPS has a Altman-Z score (1.18) which is in line with its industry peers.
  • MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.18
ROIC/WACCN/A
WACC9.03%
MYPS Yearly LT Debt VS Equity VS FCFMYPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • MYPS has a Current Ratio of 3.12. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of MYPS (3.12) is better than 88.61% of its industry peers.
  • MYPS has a Quick Ratio of 3.12. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
  • MYPS has a Quick ratio of 3.12. This is amongst the best in the industry. MYPS outperforms 88.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 3.12
MYPS Yearly Current Assets VS Current LiabilitesMYPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MYPS Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.55% over the past year.
  • Looking at the last year, MYPS shows a very negative growth in Revenue. The Revenue has decreased by -18.77% in the last year.
  • Measured over the past years, MYPS shows a decrease in Revenue. The Revenue has been decreasing by -2.72% on average per year.
EPS 1Y (TTM)4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.89%
Revenue 1Y (TTM)-18.77%
Revenue growth 3Y-6.79%
Revenue growth 5Y-2.72%
Sales Q2Q%-18.26%

3.2 Future

  • MYPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.00% yearly.
  • MYPS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.60% yearly.
EPS Next Y9.33%
EPS Next 2Y15.8%
EPS Next 3Y28%
EPS Next 5YN/A
Revenue Next Year-10.15%
Revenue Next 2Y-8.73%
Revenue Next 3Y-4.6%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYPS Yearly Revenue VS EstimatesMYPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MYPS Yearly EPS VS EstimatesMYPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

2

4. MYPS Valuation Analysis

4.1 Price/Earnings Ratio

  • MYPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MYPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYPS Price Earnings VS Forward Price EarningsMYPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • 96.20% of the companies in the same industry are more expensive than MYPS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.43
EV/EBITDA -2.88
MYPS Per share dataMYPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MYPS's earnings are expected to grow with 28.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.8%
EPS Next 3Y28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MYPS Dividend Analysis

5.1 Amount

  • No dividends for MYPS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYPS Fundamentals: All Metrics, Ratios and Statistics

PLAYSTUDIOS INC

NASDAQ:MYPS (5/1/2026, 8:00:01 PM)

After market: 0.4115 -0.01 (-1.32%)

0.417

+0 (+0.46%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Industry Strength9.94
Industry Growth72.05
Earnings (Last)03-16
Earnings (Next)05-11
Inst Owners36.69%
Inst Owner Change-0.09%
Ins Owners3.73%
Ins Owner Change0.07%
Market Cap53.51M
Revenue(TTM)235.10M
Net Income(TTM)-28.64M
Analysts76.36
Price Target1.36 (226.14%)
Short Float %3.45%
Short Ratio9.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-192.95%
Min EPS beat(2)-217.96%
Max EPS beat(2)-167.93%
EPS beat(4)0
Avg EPS beat(4)-113.02%
Min EPS beat(4)-217.96%
Max EPS beat(4)-15.34%
EPS beat(8)2
Avg EPS beat(8)-60.78%
EPS beat(12)5
Avg EPS beat(12)-74.12%
EPS beat(16)8
Avg EPS beat(16)-14.6%
Revenue beat(2)0
Avg Revenue beat(2)-3.62%
Min Revenue beat(2)-3.84%
Max Revenue beat(2)-3.41%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-5.61%
Max Revenue beat(4)-3.41%
Revenue beat(8)2
Avg Revenue beat(8)-2.7%
Revenue beat(12)4
Avg Revenue beat(12)-1.63%
Revenue beat(16)6
Avg Revenue beat(16)-0.78%
PT rev (1m)-23.81%
PT rev (3m)-23.81%
EPS NQ rev (1m)1.58%
EPS NQ rev (3m)-25.02%
EPS NY rev (1m)-79.49%
EPS NY rev (3m)-79.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.19%
Revenue NY rev (1m)-7.76%
Revenue NY rev (3m)-9.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF 5.43
P/OCF 2.03
P/B 0.23
P/tB 0.54
EV/EBITDA -2.88
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)0.08
FCFY18.4%
OCF(TTM)0.21
OCFY49.23%
SpS1.83
BVpS1.78
TBVpS0.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -9.85%
ROE -12.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.56%
FCFM 4.19%
ROA(3y)-8.01%
ROA(5y)-5.18%
ROE(3y)-10.34%
ROE(5y)-6.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.3%
GM growth 5Y2.71%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43%
Cap/Sales 7.02%
Interest Coverage N/A
Cash Conversion 146.99%
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 3.12
Altman-Z 1.18
F-Score6
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)54.83%
Cap/Depr(5y)81.52%
Cap/Sales(3y)8.42%
Cap/Sales(5y)10.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.89%
EPS Next Y9.33%
EPS Next 2Y15.8%
EPS Next 3Y28%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.77%
Revenue growth 3Y-6.79%
Revenue growth 5Y-2.72%
Sales Q2Q%-18.26%
Revenue Next Year-10.15%
Revenue Next 2Y-8.73%
Revenue Next 3Y-4.6%
Revenue Next 5YN/A
EBIT growth 1Y-185.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258%
EBIT Next 3Y52.11%
EBIT Next 5YN/A
FCF growth 1Y-57.44%
FCF growth 3YN/A
FCF growth 5Y-14.38%
OCF growth 1Y-42.41%
OCF growth 3Y-7.59%
OCF growth 5Y-11.46%

PLAYSTUDIOS INC / MYPS Fundamental Analysis FAQ

What is the fundamental rating for MYPS stock?

ChartMill assigns a fundamental rating of 3 / 10 to MYPS.


Can you provide the valuation status for PLAYSTUDIOS INC?

ChartMill assigns a valuation rating of 2 / 10 to PLAYSTUDIOS INC (MYPS). This can be considered as Overvalued.


What is the profitability of MYPS stock?

PLAYSTUDIOS INC (MYPS) has a profitability rating of 3 / 10.